What did @waldorfwellness actually say?
Honestly, the transcript here is a problem. What was captured word-for-word reads like song lyrics, not a wellness explanation. That means we cannot directly quote any specific peptide claims from what was actually said on camera. What we can work with is the caption, which describes feeling "stuck" with weight gain, exhaustion, slow recovery, and brain fog during perimenopause, and credits peptides with helping "a LOT." That framing is doing real clinical work, and it deserves scrutiny.
The caption stops short of naming specific peptides or dosing, which is either responsible restraint or a deliberate strategy to avoid platform flags while still implying therapeutic benefit. Either way, the hashtags, specifically "healingpeptides" and "peptidesforwomen," are pointing an audience toward a category of compounds that ranges from reasonably studied to essentially unregulated.
Does the science back this up?
Partially, and with significant asterisks. Some peptides have real research behind them. Most of what gets sold to perimenopausal women online does not.
Growth hormone-releasing peptides like ipamorelin and CJC-1295 have been studied for their effects on body composition, sleep quality, and recovery, all symptoms this creator describes. A 2019 review in Growth Hormone and IGF Research (Sigalos and Pastuszak) noted that GHRH analogs can meaningfully increase IGF-1 and lean mass in adults with growth hormone deficiency, but effects in healthy middle-aged women without diagnosed deficiency are far less clear. BPC-157 has shown tissue repair effects in animal models (Sikiric et al., multiple publications in Current Pharmaceutical Design), but human randomized controlled trial data remains sparse. GHK-Cu has some credible anti-inflammatory and collagen-related literature. MK-677, despite its peptide-adjacent marketing, is an orally active secretagogue with a more complex risk profile including insulin resistance and edema. Lumping these together as a category that helps with perimenopause symptoms is a stretch the evidence does not comfortably support.
What did they get wrong (or right)?
Credit where it is due: describing perimenopause symptoms as something other than just "normal aging" is actually correct and worth saying. Research consistently shows this phase is underdiagnosed and undertreated. A 2021 paper in Climacteric (Monteleone et al.) documented how women in perimenopause report fatigue, cognitive changes, and weight redistribution as primary complaints that clinicians frequently dismiss.
Where this gets messy is the implied causation. Feeling better after starting peptides during perimenopause could reflect the peptides, a concurrent lifestyle change, placebo response, or simply the natural fluctuation of hormonal symptoms over time. The caption does not acknowledge any of that complexity. Attributing symptom improvement to "peptides" without ruling out confounders is not science communication, it is testimonial marketing. The audience watching this is not getting a balanced picture of what we know versus what is being hoped for.
What should you actually know?
If you are a perimenopausal woman researching peptides after watching content like this, here is the honest version. Some peptides are prescribed legally through licensed providers and compounding pharmacies, and some have reasonable rationale for use in specific clinical contexts. Most are not FDA-approved for the symptoms being described. Compounded peptides vary in purity and dosing accuracy in ways that brand-name pharmaceuticals do not. The FDA has placed several peptides, including BPC-157 and TB-500, on a list of compounds that cannot be legally compounded for human use.
That does not mean zero benefit is possible. It means the risk-benefit calculation is genuinely unclear, and you deserve to know that before spending money or injecting something based on an Instagram caption. A telehealth provider who orders labs, reviews your hormone panel, and discusses peptide options in the context of your full clinical picture is a very different thing from following a wellness influencer's implied protocol.
- Ask any provider recommending peptides which ones are currently legal to compound in the U.S.
- Request to see the Certificate of Analysis for any compounded peptide product.
- Distinguish between symptom overlap, perimenopause is hormonal, and what peptides actually address mechanistically.